{"id":"https://openalex.org/W2410009846","doi":"https://doi.org/10.1248/yakushi1947.107.9_732","title":"Studies on Synthesis of Water-Soluble Chymotrypsin Inhibitors","display_name":"Studies on Synthesis of Water-Soluble Chymotrypsin Inhibitors","publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W2410009846","doi":"https://doi.org/10.1248/yakushi1947.107.9_732","mag":"2410009846","pmid":"https://pubmed.ncbi.nlm.nih.gov/3437400"},"language":"ja","primary_location":{"id":"doi:10.1248/yakushi1947.107.9_732","doi":"https://doi.org/10.1248/yakushi1947.107.9_732","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.107.9_732","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/107/9/107_9_732/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/yakushi1947/107/9/107_9_732/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007777630","display_name":"Nobuo Yokoo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"NOBUO YOKOO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111990513","display_name":"EIZOU HATTORI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"EIZOU HATTORI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103631189","display_name":"Mitsuteru Hirata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MITSUTERU HIRATA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100845155","display_name":"Koichiro Watanabe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KOICHIRO WATANABE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110007515","display_name":"Fumiyasu Sato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FUMIYASU SATO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083519029","display_name":"Masahiko Nagakura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MASAHIKO NAGAKURA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113507238","display_name":"Setsuro Fujii","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SETSURO FUJII","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.25855113,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"107","issue":"9","first_page":"732","last_page":"737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.08579999953508377,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chymotrypsin-inhibitor","display_name":"chymotrypsin inhibitor","score":0.9900000095367432},{"id":"https://openalex.org/keywords/water-soluble-inhibitors","display_name":"water-soluble inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/chymotrypsin","display_name":"chymotrypsin","score":0.6790000200271606},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.45100000500679016},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8851574659347534},{"id":"https://openalex.org/C2778401398","wikidata":"https://www.wikidata.org/wiki/Q383836","display_name":"Chymotrypsin","level":4,"score":0.8421546220779419},{"id":"https://openalex.org/C2779074116","wikidata":"https://www.wikidata.org/wiki/Q134856","display_name":"Carboxylic acid","level":2,"score":0.731417715549469},{"id":"https://openalex.org/C2777702071","wikidata":"https://www.wikidata.org/wiki/Q130336","display_name":"Phenol","level":2,"score":0.6448915004730225},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.6413962244987488},{"id":"https://openalex.org/C2779255514","wikidata":"https://www.wikidata.org/wiki/Q179724","display_name":"Naphthalene","level":2,"score":0.591615617275238},{"id":"https://openalex.org/C2776309666","wikidata":"https://www.wikidata.org/wiki/Q408384","display_name":"Quinoline","level":2,"score":0.526687502861023},{"id":"https://openalex.org/C2778216191","wikidata":"https://www.wikidata.org/wiki/Q420416","display_name":"Tetralin","level":3,"score":0.48496484756469727},{"id":"https://openalex.org/C2778074193","wikidata":"https://www.wikidata.org/wiki/Q3498942","display_name":"Carboxylate","level":2,"score":0.4364606738090515},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.43493354320526123},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.43092411756515503},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4043489694595337},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.36812126636505127},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.35135215520858765},{"id":"https://openalex.org/C2780340462","wikidata":"https://www.wikidata.org/wiki/Q127450","display_name":"Trypsin","level":3,"score":0.2473732829093933},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.07253032922744751}],"mesh":[{"descriptor_ui":"D002918","descriptor_name":"Chymotrypsin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009280","descriptor_name":"Naphthaleneacetic Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009280","descriptor_name":"Naphthaleneacetic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/yakushi1947.107.9_732","doi":"https://doi.org/10.1248/yakushi1947.107.9_732","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.107.9_732","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/107/9/107_9_732/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},{"id":"pmid:3437400","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3437400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","raw_type":"English Abstract"}],"best_oa_location":{"id":"doi:10.1248/yakushi1947.107.9_732","doi":"https://doi.org/10.1248/yakushi1947.107.9_732","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.107.9_732","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/107/9/107_9_732/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2410009846.pdf","grobid_xml":"https://content.openalex.org/works/W2410009846.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4244370077","https://openalex.org/W2142443281","https://openalex.org/W1971483491","https://openalex.org/W2168764714","https://openalex.org/W1972042330","https://openalex.org/W1964213175","https://openalex.org/W2949466603","https://openalex.org/W2982006741","https://openalex.org/W6936404880","https://openalex.org/W7198187956"],"abstract_inverted_index":{"Synthesis":[0],"of":[1,12,23,46,69,97,122],"water-soluble":[2],"chymotrypsin":[3],"specific":[4],"inhibitors":[5],"was":[6],"attempted":[7],"to":[8],"study":[9],"the":[10,21,77,120],"roles":[11],"chymotrypsin-like":[13],"enzymes":[14],"in":[15],"vivo.":[16],"Previously":[17],"we":[18,41],"reported":[19],"that":[20],"esters":[22,45,68],"carboxylic":[24,47,100,104],"acid":[25,48,71,75,101],"containing":[26,35,49,106],"a":[27,36,50,107],"condensed":[28,51],"ring":[29,38],"showed":[30,76],"stronger":[31],"activity":[32],"than":[33,94],"those":[34],"single":[37],"system.":[39],"Then":[40],"synthesized":[42],"4-substituted":[43,115],"phenyl":[44],"ring,":[52],"such":[53],"as":[54],"tetralin,":[55],"naphthalene,":[56],"indole":[57],"etc.,":[58],"and":[59,73,80,90,102,118],"their":[60,81],"inhibitory":[61],"activities":[62],"were":[63,84],"compared.":[64],"Among":[65],"these":[66],"compounds,":[67],"tetralin-1-carboxylic":[70],"(FK-448)":[72],"1-naphthylacetic":[74],"strongest":[78],"activity,":[79],"IC50":[82],"values":[83],"8\u00d710-7,":[85],"5\u00d710-7":[86],"M,":[87],"respectively.":[88],"Tetralin-2-carboxylate":[89],"2-naphthylacetate":[91],"inhibited":[92,110],"weaker":[93],"1-analogues.":[95],"Esters":[96],"basic":[98],"quinoline":[99],"bulky":[103],"acids":[105],"three-ring":[108],"system":[109],"poorly.":[111],"Chymotrypsin":[112],"produced":[113],"equimolecular":[114],"phenol":[116,124],"rapidly":[117],"thereafter":[119],"amount":[121],"4-substituded":[123],"increased":[125],"slowly,":[126],"when":[127],"incubated":[128],"with":[129],"FK-448":[130],"at":[131],"37\u00b0C.":[132]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}